ChatDocto
Find a doctor
Two-tone pharmaceutical capsule

XERACTAN 10 mg

Isotretinoine · soft capsules

B/30Oral use
25,180 DTRecorded public price · B/30
See all pack prices
Strength10 mg
Therapeutic classMEDICAMENTS DERMATOLOGIQUES

About this medicine

XERACTAN 10 mg soft capsules is listed in Tunisia's medicine catalog under the active ingredient Isotretinoine. This page brings together its recorded pack formats, prices and CNAM coverage information.

What is this medicine used for?

Review pending

A reviewed explanation of uses is not yet published for this medicine in this language. Ask a pharmacist for the leaflet for your exact product.

What side effects should I know about?

Review pending

A reviewed side-effect guide is not yet published for this medicine in this language. This does not mean that the medicine has no side effects. Read your product leaflet or ask a pharmacist.

Price by pack

Compare the recorded price for each exact pack. A catalog entry does not confirm pharmacy stock.

  • Pack · B/30

    30 units in this pack

    Recorded public price25,180 DT
    AMM No.
    12673021
    CNAM code
    106043
    CNAM reference amount
    18,060 DT

    Price source: CNAM — Liste des médicaments remboursables · 2026-08-04

    Source recorded: August 23, 2026

    Price effective date not provided

This reference amount is not a guaranteed refund or a personal out-of-pocket estimate. Your coverage conditions must be confirmed separately.

Medicine details

Dosage formsoft capsules
Route of administrationOral use
LaboratoryJazeera Pharmaceutical Industries
OriginGeneric
ScheduleA
Therapeutic classMEDICAMENTS DERMATOLOGIQUES

Medicines with matching catalog characteristics

These entries match the recorded ingredient, strength, form and route. This does not establish that they can replace your medicine; confirm any change with a pharmacist.

CURACNE GÉ 10 mgCapsules mollesPIERRE FABRE DERMATOLOGIE · B/30
Recorded public price29,045 DT

Price source: CNAM — Liste des médicaments remboursables · 2026-08-04

Source recorded: August 23, 2026